Arcus Biosciences, Inc. (RCUS) has a consensus analyst rating of Buy, based on 18 analysts covering the stock. Of those, 15 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for RCUS is $28.00, representing a +21.7% upside from the current price of $23.01. Price targets range from a low of $20.00 to a high of $35.00.
